During a 2-year period, all children with cancer, neutropenia, and fever who were admitted to Hospital de Niñ os Luis Calvo Mackenna (Santiago, Chile) were enrolled in a study of the safety of stopping antibiotic therapy on day 3 of treatment. Children who met predefined criteria for nonbacterial fever were randomized on day 3 to stop (group A) or continue (group B) antibiotic therapy. A total of 220 children with cancer had 238 episodes of fever and neutropenia; 68 children with 75 episodes met entry criteria for nonbacterial fever (group A, 36; group B, 39). Both groups were comparable in terms of age, gender, oncological disease, chemotherapy status, and initial neutrophil count. Resolution of symptoms occurred in 34 of 36 episodes in group A and 36 of 39 episodes in group B (P ú .05). No deaths occurred, and bacterial superinfections were uncommon. For children with cancer as well as episodes of fever and neutropenia without an identifiable bacterial etiology at admission, stopping antibiotic therapy on day 3 was safe and not associated with a higher risk of bacterial superinfections.
In children with cancer, infections represent a major cause During the past 5 years, we have developed strategies for selective antibiotic management of fever and neutropenia in of morbidity and mortality. Infections are favored by the impairment of host defense mechanisms induced by the cancer children with cancer. We have focused on the use of serum CRP as a marker for bacterial infection because it is inexpenand the use of chemotherapy [1 -3] . Neutropenia is an expected side effect of chemotherapy, and the relationship between the sive to determine and because we have experience with this laboratory parameter in immunocompetent and immunoseverity and duration of neutropenia and infection has been well established [4] . The risk of infection increases significantly deficient children [14 -17] . when the absolute neutrophil count (ANC) falls to õ500/mm 3 We [17] previously reported that children with leukemia, [5] , and infection occurs almost invariably when the ANC lymphoma, or solid tumors have baseline serum CRP levels decreases to 100/mm 3 [6] . comparable with those in healthy children, variations in CRP The high impact of infections in children with cancer and levels are sensible and specific markers for bacterial infections neutropenia on morbidity and mortality has led to aggressive in the presence of fever and neutropenia, and serial determinamanagement of these children when a febrile episode occurs.
tions of CRP levels aid in determining the group of children With the aim of reducing the impact of infections on the for whom treatment fails or who have bacterial superinfecprognosis of oncological disease, different strategies have tions during their clinical course. In our experience, etiologic been developed: e.g., prevention of episodes of fever by workup of febrile episodes in Chilean children with cancer means of antimicrobial therapy [7] ; reduction of the frequency and neutropenia shows that 30% -35% of patients have demof or shortening the duration of episodes of neutropenia after onstrated bacterial infection; 30% -35% have probable, albeit chemotherapy by using colony-stimulating factors [8] ; or betnot documented, bacterial infection; 30% have demonstrated ter discrimination of which episodes of fever may be occurring viral infection or fever of unknown origin without clinical with a bacterial infection and thus benefit from antimicrobial and laboratory evidence of bacterial and/or viral infections; treatment [9, 10] . To accomplish the last objective, researchand 10% have fungal infection (unpublished data, M. E. ers have studied endotoxins, interleukin 6, tumor necrosis Santolaya). factor, and C-reactive protein (CRP) as markers for bacterial According to statistics from Programa Infantil Nacional de infection [11 -13] .
Drogas Antineoplásicas, which is supported by the Chilean Ministry of Health, there were ú1,500 pediatric patients with cancer in Chile during the past 5 years (1989 -1993) . This of this policy include overuse of antibiotics, prolonged hospitalepisode of fever and neutropenia was resolved. Trimethoprimsulfamethoxazole prophylaxis is not routinely administered to ization with a psychological burden for the patient and the patient's family, the risk of colonization and emergence of children with cancer and neutropenia in our hospital, and this therapy was not given to any of the study patients. multidrug-resistant bacterial strains, and a significant increase in the cost of patient management [19 -21] .
Patient follow-up. Children from both groups were monitored daily in the hospital until the fever resolved and the These observations led us to design a prospective, randomized study of the safety of stopping antibiotic therapy during ANC was ú500/mm
3
. Monitoring included determination of temperature and blood pressure, evaluation of consciousness day 3 of antimicrobial treatment of children with cancer and episodes of fever and severe neutropenia; these children did level and hemodynamic stability, and complete physical examination for identification of potential bacterial complications. not have evidence of bacterial infection on the basis of clinical and laboratory findings and serial CRP measurements during Blood was obtained daily for determination of CRP level and every 2 days for measurement of complete blood cell count. the first 2 days of illness. We also evaluated the usefulness of serial CRP levels for early detection of bacterial superinfections
Additional laboratory evaluations were done on the basis of individual clinical findings. during the course of the neutropenic episode.
Outcome variables. The following variables were considered indicative of an unfavorable outcome determining reMaterials and Methods starting antibiotic therapy for children in group A and adjusting antibiotic therapy for children in group B: detection of Population selection. All children hospitalized at Hospital de Niños Luis Calvo Mackenna (Santiago, Chile) because of a clinical focus suggestive of a bacterial infection, a positive bacterial culture after day 3, reappearance of fever, deterioracancer, fever, and severe neutropenia (ANC, £500/mm 3 ) from 1 January 1994 to 31 January 1996 were eligible for enrollment.
tion of hemodynamic stability that was not attributable to blood loss, or progressive increase in serum CRP levels to This center is a public hospital affiliated with the Universidad de Chile; it provides health care to 400,000 children in the low ú40 mg/L during at least two consecutive measurements. Outcome was defined as favorable when none of the aboveto average income population.
Initial evaluation. All children underwent a thorough clinimentioned variables occurred. Determination of CRP level. Blood for determination of cal evaluation performed by one of the authors (M.E.S. or M.V.), and the following standard laboratory tests were carried CRP level was obtained by thumb prick and processed as previously described [15] . Briefly, 20 mL of serum was incubated out: determination of complete blood cell count, liver and renal function tests, chest roentgenography, urine sediment and urine with antiserum to CRP (Orion Diagnóstica, Espoo, Finland) and a control (4% polyethylene glycol) for 15 minutes. Formacultures, and blood cultures (including quantitative cultures if an indwelling central venous catheter was present). Quantitation of the antiserum to CRP complex was detected by light refraction with use of a Turbox nephelometer (Orion Diagnós-tive serum CRP levels were determined at admission and on day 2. The following examinations were performed according tica)). The quantity of complex formation was measured in milligrams per liter. A CRP level of £10 mg/L was considered to clinical findings: serial stool cultures, rotavirus detection, ova and parasite detection, bacterial and fungal cultures of normal [22] . According to our experience with CRP levels and infections in immunocompetent and immunocompromised pharyngeal and skin specimens, indirect immunofluorescence of nasopharyngeal aspirates for detection of respiratory syncyhosts [17] , a cutoff value of 40 mg/L was used for bacterial infection. tial virus, adenovirus, parainfluenza virus types 1, 2, and 3, and influenza virus types A and B, and adenovirus culture.
Definitions. The following definitions were used in this study: fever, two axillary temperatures of §38ЊC separated by Therapy with an antistaphylococcal penicillin and a thirdgeneration cephalosporin or an aminoglycoside was started at 1 hour; hemodynamic instability, systolic blood pressure below the 5th percentile for age and/or capillary refill of ú3 seconds admission for all children; all children were monitored daily by one of the authors (M. E. S or M. V.). All children who had
[23]; demonstrated bacterial infection, one or more blood cultures positive for a bacterial pathogen, two or more blood clinical and/or laboratory evidence of bacterial infection and/or a serum CRP level of ú40 mg/L on day 1 or 2 were considered cultures positive for an opportunistic pathogen, and/or a positive bacterial culture of a specimen from any other sterile site; potentially bacteremic and were excluded from the study. Children with no identifiable focus of bacterial infection, hemodyprobable bacterial infection, absence of an identifiable bacterial pathogen in the presence of hemodynamic instability and innamic stability, negative admission cultures, and serum CRP levels of £40 mg/L on days 1 and 2 were considered at low tense malaise and/or results of physical and laboratory evaluations that are suggestive of a bacterial focus and a serum CRP risk for bacterial infection. These children continued in the study. They were randomized on day 3 
Results

Figure 1. Algorithm describing the randomization of children with
Population. During the 25-month study period, 220 pacancer, neutropenia, and fever to two study groups: group A, all tients with cancer who had 238 episodes of fever and neutroantibiotic therapy stopped; group B, antibiotic therapy continued until penia were admitted to our hospital. All patients received antithe episode of neutropenia and fever was resolved.
biotic therapy and were evaluated daily according to the study protocol. On day 3, 149 febrile episodes were excluded from the study because they were associated with clinical signs of Mixed viral and bacterial infections occurred in three children: one child admitted with varicella, one with an upper bacterial infection, positive bacterial cultures, and serum CRP levels of ú40 mg/L. For this group of patients with 149 febrile respiratory tract infection, and one with an enterovirus infection who acquired Enterobacter aerogenes bacteremia, pneumonia episodes, the mean CRP value { SD was 101 { 48.7 mg/L and the discharge diagnoses included demonstrated bacterial (indicated by radiological findings), and periodontal abscess, respectively. Two children developed indwelling central veinfection (46%), probable bacterial infection (38%), bacterial and fungal infections (8%), fungal infection (5%), viral infecnous catheter -associated infection due to coagulase-negative staphylococcus. Eighteen episodes were classified as FUO. tion (2%), and mixed infection (1%). For this group of children, the mean duration of neutropenia ({ SD) was 9 { 5.38 days, Clinical outcome by study groups. The mean duration of fever { SD was 2.7 { 1.82 days in group A and 3.5 { 3.62 which did not differ from those for the study groups (Student's t test). days in group B (NS, Mann-Whitney U test). In group A, antibiotic therapy was stopped in 29 febrile episodes that reOf the 89 febrile episodes associated with low serum CRP levels and the absence of clinical and laboratory evidence of solved and in seven febrile episodes despite continuous fever. The mean duration of severe neutropenia { SD was 8.3 { bacterial infection, 14 were excluded from the study because antimicrobial treatment was administered during the 7 days 5.42 days in group A and 9.0 { 5.83 days in group B (NS, Student's t test). Hospital stay was determined by the duration before admission. The remaining 68 patients with 75 febrile episodes (seven children had two episodes) were randomized of neutropenia according to the protocol; the mean hospital stay { SD was similar in both groups (8 { 5.22 days for group to group A (n Å 36) or group B (n Å 39) (figure 1).
Characteristics of study groups. Groups A and B were A vs. on day 2 but reappeared 48 hours later with increasing CRP Fever reappeared on day 5, the CRP level increased to a maximum of 98 mg/L on day 5, and two repeated blood cultures levels (which reached a maximum of 81 mg/L on day 5) and increasing malaise. Antibiotic therapy was restarted; all culwere positive for E. aerogenes resistant to third-generation cephalosporins. Antibiotic therapy (imipenem) was started; the tures were negative, and the child fully recovered after 3 days. Antibiotic therapy for another child in group A, an 8-year-old patient had an uneventful course and recovered after 7 days. In group B, treatment failed in three episodes. Two boys (a girl with osteosarcoma who enrolled in the study with a clinical diagnosis of varicella and a CRP level of 30 mg/L, was stopped 3-year-old and a 7-year-old) with acute lymphoblastic leukemia and a history of use of indwelling central venous catheters at 72 hours; only intravenous acyclovir therapy was maintained.
developed catheter infection due to coagulase-negative staphylococcus despite the fact that antibiotic treatment was continued; therapy was changed from cloxacillin to vancomycin. The Table 2 . Discharge diagnoses for 68 children with cancer who had serum CRP levels increased to ú40 mg/L in the 3-year-old 75 episodes of severe neutropenia and fever.
boy, while repeated CRP levels in the 7-year-old boy remained
No. of episodes with indicated diagnosis at õ40 mg/L. The third child, a 9-year-old boy with a relapse of acute nonlymphoblastic leukemia who was enrolled in the / 9c33$$jy17 06-10-97 09:54:19 cida UC: CID of fever and increasing CRP levels that reached a maximum The previous observation that the serum CRP level could be a sensitive marker for the occurrence of a bacterial superinfecof 153 mg/L. Antibiotic treatment was changed, and the child recovered after 3 days.
tion during the clinical course of children admitted to the hospital with nonbacterial fever was also confirmed in this prospective study [18] . All 70 episodes with a favorable clinical course Discussion were associated with serial CRP levels of õ40 mg/L, while four of five episodes in children who presented with a bacterial In most pediatric cancer centers worldwide, children with cancer and neutropenia who develop a febrile episode receive superinfection were associated with increasing serum CRP levels that were greater than the cutoff value. It is notable that in-hospital treatment that includes broad-spectrum antibiotics. More recently, a less aggressive, more selective approach serum CRP levels remained below the cutoff value in one of the two children who had an indwelling central venous catheteraimed at determining relevant risk factors that could help identify patients with fever and concomitant bacterial infection has associated infection due to coagulase-negative staphylococcus. This finding has been reported by other investigators [26] and been proposed [24] .
Previous studies [17, 18] have reported that 30% of children suggests that patients with cancer, neutropenia, and fever who have an indwelling catheter may be infected with a coagulasewith cancer, fever, and neutropenia lack clinical or laboratory evidence of a bacterial infection, an observation that was connegative staphylococcus despite persistently low serum CRP levels. The appropriate antibiotic management for this particufirmed in our study where 26% of 220 patients had a viral infection. An additional 8% of patients lacked evidence of lar group of children will require additional study. In summary, we propose that children with cancer, fever, bacterial and viral infections and were classified as having FUO. Continuous enrollment of patients during a 2-year study and neutropenia who are at low risk for bacterial infection according to predefined criteria can be safely managed without period removes the possible influence of seasonality in the identification rate for viral infections. However, determining antibiotic therapy after day 3. We strongly believe that this selective approach can benefit many patients who will be at the true role of viruses in these febrile episodes will require performing a complete virological workup for all children with lower risk for antibiotic-associated complications. The adoption of this strategy must be closely evaluated by each institucancer, neutropenia, and fever (not only for those with clinical signs of a viral infection and a CRP level of õ40 mg/L as in tion because of the possibility of local differences in patient populations and in clinical and laboratory monitoring. A carethis study).
Our results strongly suggest that children with cancer and fully designed protocol or strict criteria must be used to avoid the occurrence of serious complications. The duration of inneutropenia who develop fever and lack clinical and laboratory evidence of a bacterial infection according to well-defined critehospital observation will also have to be carefully determined.
Although the relatively small size of our groups could be ria (which in our study included at least two CRP levels of õ40 mg/L) can be managed without antibiotic therapy after seen as a limitation of our study, the results highly favored the hypothesis that stopping antibiotic therapy for children at low day 3 and not be at an increased risk for an unfavorable outcome. The findings of our initial study [17] , which proved that risk for bacterial infection is safe. In Santiago, our observations have prompted the development of a multicenter protocol for a serum CRP level of õ40 mg/L in children with cancer, neutropenia, and fever is a sensitive and specific marker for the management of these children. In this protocol, we consider stopping antibiotic therapy for children with cancer, fever, and nonbacterial fever, have been confirmed by this prospective, randomized study. neutropenia according to the same clinical and laboratory criteria described in this article. Additional support for this selective approach comes from the analysis of the two cases in group A and the three cases Until further experience is obtained, we recommend in-hospital follow-up for these children up to the time that the ANC in group B that had an unfavorable outcome. Organisms not covered by the empirical antibiotic therapy usually used at is ú500/mm 3 ; follow-up should include daily clinical evaluation and determination of serum CRP levels. Close monitoring admission were recovered from one of the two children with bacterial superinfections in group A; therefore, it is probable of this protocol will allow us to evaluate our observations on a wide-scale basis in the future, extend our recommendations, that the superinfections would have occurred with or without antibiotic use.
critically analyze potential pitfalls of this approach, and determine the potential economic benefit of these recommendations On the other hand, adjustment of wide-spectrum antibiotic therapy for the three children in group B who had superinfecfor the Chilean National Health Care System. tions was required, which suggests that the antibiotic coverage was most probably not affording a specific benefit against the infectious process. Other investigators [25] have shown that 
